tiprankstipranks
Advertisement
Advertisement

WALD Stock Latest News

Waldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority
Company AnnouncementsWaldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority
21d ago
6K
WALD
Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt
PremiumCompany Announcements
Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt
27d ago
6K
WALD
Waldencast Closes $460 Million Sale of Obagi Medical, Refocuses on Milk Makeup
PremiumCompany Announcements
Waldencast Closes $460 Million Sale of Obagi Medical, Refocuses on Milk Makeup
27d ago
6K
WALD
Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus
PremiumCompany Announcements
Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus
1M ago
6K
WALD
Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ
PremiumCompany Announcements
Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ
2M ago
6K
WALD
Waldencast announces regulatory approval of Obagi dermal filler
PremiumThe FlyWaldencast announces regulatory approval of Obagi dermal filler
2M ago
WALD
Waldencast price target raised to $3 from $2 at Canaccord
Premium
The Fly
Waldencast price target raised to $3 from $2 at Canaccord
3M ago
WALD
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup
Premium
Company Announcements
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup
3M ago
6K
WALD
Waldencast to sell Obagi Medical to Bridgepoint for up to $460M
PremiumThe Fly
Waldencast to sell Obagi Medical to Bridgepoint for up to $460M
3M ago
WALD
WALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
WALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
WALD
Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target
PremiumRatings
Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target
4M ago
WALD
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues
PremiumCompany Announcements
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues
4M ago
6K
WALD
Obagi Medical, ProMD collaborate for ALOHA program
PremiumThe FlyObagi Medical, ProMD collaborate for ALOHA program
5M ago
WALD
Obagi Medical, ProMD collaborate for ALOHA program
Premium
The Fly
Obagi Medical, ProMD collaborate for ALOHA program
5M ago
WALD
Waldencast price target lowered to $2.50 from $3.50 at Alliance Global
Premium
The Fly
Waldencast price target lowered to $2.50 from $3.50 at Alliance Global
5M ago
WALD
Waldencast price target lowered to $2 from $3 at Telsey Advisory
PremiumThe Fly
Waldencast price target lowered to $2 from $3 at Telsey Advisory
5M ago
WALD
Waldencast price target lowered to $2 from $4 at Canaccord
PremiumThe Fly
Waldencast price target lowered to $2 from $4 at Canaccord
5M ago
WALD
Waldencast price target lowered to $2 from $4 at Canaccord
PremiumThe Fly
Waldencast price target lowered to $2 from $4 at Canaccord
6M ago
WALD
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
PremiumCompany Announcements
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
6M ago
6K
WALD
Waldencast reports Q4 revenue $72M vs. $72.1M last year
PremiumThe FlyWaldencast reports Q4 revenue $72M vs. $72.1M last year
6M ago
WALD
Obagi Medical, Schweiger Dermatology collaborate for ALOHA program
Premium
The Fly
Obagi Medical, Schweiger Dermatology collaborate for ALOHA program
6M ago
WALD
Obagi Medical, It’s a Secret Med Spa collaborate for ALOHA program
Premium
The Fly
Obagi Medical, It’s a Secret Med Spa collaborate for ALOHA program
6M ago
WALD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >